HENDERSON, Nev., Nov. 12, 2007 (PRIME NEWSWIRE) -- BodyTel Scientific, Inc. (OTCBB:BDYT), a developer of wireless telemedical measuring devices, announced that management will be presenting the GlucoTel telehealth solution at the international medical fair, Medica 2007, from November 14-17, 2007 in Dusseldorf, Germany. The company's blood glucose monitoring and diabetes self-management system will be demonstrated at hall 3, booth E42. BodyTel Scientific is in the process of preparing for the commercial launch of GlucoTel in all CE-relevant markets, anticipated in the first quarter of 2008.
"GlucoTel offers a user-friendly telemedical self-management system for patients with diabetes," states Stefan Schraps, CEO of BodyTel. "Mobile phones are always at hand these days. Our blood glucose meter sends the blood sugar value via Bluetooth to the patient's mobile phone. Then the data is processed via text message or internet connection to a password protected internet database, the BodyTel Center. The central point of communication is the mobile phone which receives as well as automatically sends data. It also sends calibration codes and information like date and time to the meter. Additionally, today's mobile phones have large color displays that are ideal to show gradients and add additional information like meals, medication, exercises, etc. Mobile phones can even read out the values loudly if requested which would be extremely beneficial to elderly diabetes patients with poor eye sight."
"The Medica 2007 offers us the perfect opportunity to present the world's first integrated telehealth system, GlucoTel, to industry experts before its market launch," continued Mr. Schraps. The MEDICA trade fair, titled the 39th World Forum for Medicine (www.medica.de), is the world's largest healthcare technologies trade fair. The 2007 MEDICA features the latest medical product developments from around the world and is expected to attract over 4,200 exhibitors from over 60 nations around the world.
The GlucoTel blood glucose meter is part of the BodyTel system, a complete telemedical diabetes self-management system supporting patients and doctors in the treatment of diabetes. The full range of BodyTel's diabetes management system comprises of GlucoTel, PressureTel -- a blood pressure measuring device and WeightTel -- a body weight and body fat scale. All devices transmit values via the patient's mobile phone to the BodyTel Center.
About BodyTel Scientific
BodyTel Scientific Inc. is a German-American telehealth company that specializes in telemedical monitoring and management systems for chronic diseases. The company combines its know-how in telecommunications, internet and medical technology/diagnostics to create new products and services for the changing needs of global health. BodyTel products are designed not only to simplify home monitoring by patients, but also to ease the communication of 'measured body values' to healthcare professionals or other caregivers by bridging the gap between the patient and the caregivers instantaneously and real-time. BodyTel's products -- GlucoTel, PressureTel and WeightTel are each at different stages of development and approval processes. Further information can be found at www.bodytel.com.
Forward-Looking Statements
Statements regarding the Company's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties that could cause actual results to differ materially from the potential results discussed in the forward-looking statements. Forward-looking statements in this press release include that BodyTel Scientific is in the process of preparing for the commercial launch of GlucoTel in all CE-relevant markets, anticipated in the first quarter of 2008 and that The Medica 2007 offers us the perfect opportunity to present the world's first integrated telehealth system, Glucotel, to industry experts before its market launch. Actual results may differ materially from those currently anticipated due to a number of factors as we may find that our products must compete with cheaper or better products; we may not be able to retain key employees; a bigger market may not develop for our products and we may not be able to continue to attract new customers; we may face litigation if our technology fails to work when required; our intellectual property may be attacked and defeated in court proceedings; our patent and FDA/CE filings may be rejected by the patent offices and regulators; other companies may discover and develop better or cheaper technologies that would render our products obsolete and we may not have sufficient funding to further develop and/or market our technology. Readers are directed to the BodyTel Scientific, Inc.'s reports as filed with the U.S. Securities and Exchange Commission from time to time, including but not limited to its 8-K filed December 14, 2006 under our prior name Sellcell.net which outlined the company's current business for further information and factors that may affect BodyTel Scientific Inc.'s business and results of operations as well as the Company's form 10-KSB filed on December 15, 2006 and the Company's form 10-QSB filed on January 16, 2007. BodyTel Scientific Inc. undertakes no obligations to publicly update any forward-looking statements to reflect future events or circumstances.